[Immunosuppressive therapy chronic polyarthritis].
D000328:Adult; D000368:Aged; D001172:Arthritis, Rheumatoid / Q000188:drug therapy*; D001379:Azathioprine / Q000009:adverse effects / Q000627:therapeutic use; D001855:Bone Marrow Diseases / Q000139:chemically induced; D002699:Chlorambucil / Q000009:adverse effects / Q000627:therapeutic use; D002986:Clinical Trials as Topic; D003520:Cyclophosphamide / Q000009:adverse effects / Q000627:therapeutic use; D004361:Drug Tolerance; D005069:Evaluation Studies as Topic; D005260:Female; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use*; D008297:Male; D008875:Middle Aged; D009150:Mustard Compounds / Q000009:adverse effects / Q000627:therapeutic use; D011344:Procarbazine / Q000009:adverse effects / Q000627:therapeutic use
D007166:Immunosuppressive Agents; D009150:Mustard Compounds; D002699:Chlorambucil; D011344:Procarbazine; D003520:Cyclophosphamide; D001379:Azathioprine
Die immunsuppressive Therapie der chronischen Polyarthritis.